(Total Views: 470)
Posted On: 10/22/2020 10:40:47 AM
Post# of 110

$SNGX News Article - Soligenix Announces Phase 3 FLASH Study Continues to Demonstrate Positive Benefits in Patients with Cutaneous T-Cell Lymphoma https://marketwirenews.com/news-releases/soli...15188.html


My Twitter: WhyteStocks